QuarterlyIQ Insights · CVS
Earnings
Next print, the company's guidance track record, and the earnings events we've seen in the last few years.
Next earnings
Average absolute move on past earnings days.
Annualized — recent baseline volatility.
Guidance track record
Of the last 2 guided quarters.
Actual vs. guided EPS, signed.
Excess return vs. sector ETF, day after print.
Earnings events
Earnings prints and pre-announcements detected in the SEC filing stream.
- 2026-05-06earnings miss
by reference. The information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (as amended, the “Exchange Act”) or otherwise subject to the liabilities of that Section, and shall not be or be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing, except as shall…
negative80 - 2026-02-10earnings inline
by reference. The information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (as amended, the “Exchange Act”) or otherwise subject to the liabilities of that Section, and shall not be or be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing, except as shall…
neutral67 - 2023-01-09earnings inline
Results of Operations and Financial Condition. Members of CVS Health Corporation’s (“CVS Health,” the “Company,” “we” or “our”) senior management team are scheduled to meet with investors beginning on January 9, 2023 and will participate in a webcast at 11:15 a.m. (Eastern Time) on January 10, 2023. During the meetings and webcast, the Company will disclose that it has reaffirmed its estimated full-year 2022 Adjusted earnings per share (“EPS”) guidance range of $8.55 to $8.65. The Company exp…
neutral67 - 2022-01-11earnings inline
Results of Operations and Financial Condition. Members of CVS Health Corporation’s (“CVS Health’s” or the “Company’s”) senior management team are scheduled to participate in a webcast at 8:15 a.m. (Eastern Time) and meet with investors on January 11, 2022. During the webcast and meetings, the Company will disclose that it has raised its full year 2021 GAAP diluted earnings per share (“EPS”) guidance range to $5.87 to $5.92 from $5.50 to $5.61 and raised its full year 2021 Adjusted EPS guidanc…
neutral67
EPS / revenue actuals and consensus per quarter (8-quarter history) need a mart view over AlphaVantage EARNINGS + EARNINGS_ESTIMATES — the backend ingest exists but isn't exposed to the frontend yet. Once that lands we can show beat/miss, surprise size, and forward consensus on this tab.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.